By Professor Miles Davenport

Journal articles

Stern J; Roche M; Solomon A; Dantanarayana A; Reynaldi A; Davenport M; Deeks SG; Hartogenesis W; Hecht FM; Cockerham L; Lewin SR, 2019, 'Cell-associated HIV RNA and the ratio of HIV RNA to DNA have circadian cycles in HIV-positive individuals on antiretoviral therapy', Journal of Virus Eradication, 5, pp. 10 - 10, http://dx.doi.org/10.1016/s2055-6640(20)31037-2

Pino M; King C; Shim I; Wang H; Nguyen K; Samer S; Harper J; Lifson J; Reynaldi A; Deleage C; Padhan K; Cervasi B; Davenport MP; Petrovas C; Lederman MM; Paiardini M, 2019, 'Fingolimod treatment at ART initiation delays SIV rebound after ART interruption', Journal of Virus Eradication, 5, pp. 3 - 3, http://dx.doi.org/10.1016/s2055-6640(20)31078-5

Betts M; Kuri Cervantes L; Pampena MB; Samer S; Khoury D; Frank I; Paiardini M; Davenport M; Bar K; Veazey R, 2019, 'Peripheral blood SIV/HIV originates from infected cells in tissues', Journal of Virus Eradication, 5, pp. 27 - 27, http://dx.doi.org/10.1016/s2055-6640(20)30142-4

Zaloumis SG; Cao P; Dini S; Davenport MP; Cromer D; Khoury DS; Fowkes FJI; McCaw JM; Simpson JA, 2018, 'In silico investigation of the decline in clinical efficacy of artemisinin combination therapies due to increasing artemisinin and partner drug resistance', Antimicrobial Agents and Chemotherapy, 62, pp. 10.1128/aac.01292 - 10.1128/aac.01218, http://dx.doi.org/10.1128/AAC.01292-18

Aogo RA; Khoury DS; Cromer D; Elliott T; Akter J; Fogg LG; Nair AS; Liligeto UN; Soon MSF; Thomas BS; Pernold CPS; Romanczuk AS; Laohamonthonkul P; Haque A; Davenport MP, 2018, 'Quantification of host-mediated parasite clearance during blood-stage Plasmodium infection and anti-malarial drug treatment in mice', International Journal for Parasitology, 48, pp. 903 - 913, http://dx.doi.org/10.1016/j.ijpara.2018.05.010

Khoury DS; Aogo R; Randriafanomezantsoa-Radohery G; McCaw JM; Simpson JA; McCarthy JS; Haque A; Cromer D; Davenport MP, 2018, 'Within-host modeling of blood-stage malaria', Immunological Reviews, 285, pp. 168 - 193, http://dx.doi.org/10.1111/imr.12697

Smithey MJ; Venturi V; Davenport MP; Buntzman AS; Vincent BG; Frelinger JA; Nikolich-Žugich J, 2018, 'Lifelong CMV infection improves immune defense in old mice by broadening the mobilized TCR repertoire against third-party infection', Proceedings of the National Academy of Sciences of the United States of America, 115, pp. E6817 - E6825, http://dx.doi.org/10.1073/pnas.1719451115

Smith NL; Patel RK; Reynaldi A; Grenier JK; Wang J; Watson NB; Nzingha K; Yee Mon KJ; Peng SA; Grimson A; Davenport MP; Rudd BD, 2018, 'Developmental Origin Governs CD8+ T Cell Fate Decisions during Infection', Cell, 174, pp. 117 - 130.e14, http://dx.doi.org/10.1016/j.cell.2018.05.029

Parsons MS; Cromer D; Davenport MP; Kent SJ, 2018, 'HIV Reactivation after Partial Protection by Neutralizing Antibodies', Trends in Immunology, 39, pp. 359 - 366, http://dx.doi.org/10.1016/j.it.2017.12.006

Aliota MT; Dudley DM; Newman CM; Weger-Lucarelli J; Stewart LM; Koenig MR; Breitbach ME; Weiler AM; Semler MR; Barry GL; Zarbock KR; Haj AK; Moriarty RV; Mohns MS; Mohr EL; Venturi V; Schultz-Darken N; Peterson E; Newton W; Schotzko ML; Simmons HA; Mejia A; Hayes JM; Capuano S; Davenport MP; Friedrich TC; Ebel GD; O’Connor SL; O’Connor DH, 2018, 'Molecularly barcoded Zika virus libraries to probe in vivo evolutionary dynamics', Plos Pathogens, 14, pp. e1006964, http://dx.doi.org/10.1371/journal.ppat.1006964

Pinkevych M; Fennessey CM; Cromer D; Tolstrup M; Søgaard OS; Rasmussen TA; Keele BF; Davenport MP, 2018, 'Estimating initial viral levels during simian immunodeficiency virus/human immunodeficiency virus reactivation from latency', Journal of Virology, 92, pp. 10.1128/jvi.01667 - 10.1128/jvi.01617, http://dx.doi.org/10.1128/JVI.01667-17

Khoury DS; Cromer D; Elliott T; Soon MSF; Thomas BS; James KR; Best SE; Aogo RA; Engel JA; Gartlan KH; Akter J; Sebina I; Haque A; Davenport MP, 2017, 'Characterising the effect of antimalarial drugs on the maturation and clearance of murine blood-stage Plasmodium parasites in vivo', International Journal for Parasitology, 47, pp. 913 - 922, http://dx.doi.org/10.1016/j.ijpara.2017.05.009

Cromer D; Pinkevych M; Rasmussen TA; Lewin SR; Kent SJ; Davenport MP, 2017, 'Modeling of antilatency treatment in HIV: What is the optimal duration of antiretroviral therapy-free HIV remission?', Journal of Virology, 91, pp. 10.1128/jvi.01395 - 10.1128/jvi.01317, http://dx.doi.org/10.1128/JVI.01395-17

Lloyd SB; Niven KP; Kiefel BR; Montefiori DC; Reynaldi A; Davenport MP; Kent SJ; Winnall WR, 2017, 'Exploration of broadly neutralizing antibody fragments produced in bacteria for the control of HIV', Human Vaccines and Immunotherapeutics, 13, pp. 2726 - 2737, http://dx.doi.org/10.1080/21645515.2017.1368935

Cao P; Klonis N; Zaloumis S; Khoury DS; Cromer D; Davenport MP; Tilley L; Simpson JA; McCaw JM, 2017, 'A mechanistic model quantifies artemisinin-induced parasite growth retardation in blood-stage Plasmodium falciparum infection', Journal of Theoretical Biology, 430, pp. 117 - 127, http://dx.doi.org/10.1016/j.jtbi.2017.07.017

Parsons MS; Lloyd SB; Lee WS; Kristensen AB; Amarasena T; Center RJ; Keele BF; Lifson JD; La Branche CC; Montefiori D; Wine BD; Hogarth PM; Swiderek KM; Venturi V; Davenport MP; Kent SJ, 2017, 'Partial efficacy of a broadly neutralizing antibody against cell-associated SHIV infection', Science Translational Medicine, 9, http://dx.doi.org/10.1126/scitranslmed.aaf1483

Lee WS; Kristensen AB; Rasmussen TA; Tolstrup M; Østergaard L; Søgaard OS; Wines BD; Mark Hogarth P; Reynaldi A; Davenport MP; Emery S; Amin J; Cooper DA; Kan VL; Fox J; Gruell H; Parsons MS; Kent SJ, 2017, 'Anti-HIV-1 ADCC antibodies following latency reversal and treatment interruption', Journal of Virology, 91, pp. 10.1128/jvi.00603 - 10.1128/jvi.00617, http://dx.doi.org/10.1128/JVI.00603-17

Khoury DS; Cromer D; Akter J; Sebina I; Elliott T; Thomas BS; Soon MSF; James KR; Best SE; Haque A; Davenport MP, 2017, 'Host-mediated impairment of parasite maturation during blood-stage Plasmodium infection', Proceedings of the National Academy of Sciences of the United States of America, 114, pp. 7701 - 7706, http://dx.doi.org/10.1073/pnas.1618939114

Vanderven HA; Liu L; Ana-Sosa-Batiz F; Nguyen THO; Wan Y; Wines B; Mark Hogarth P; Tilmanis D; Reynaldi A; Parsons MS; Hurt AC; Davenport MP; Kotsimbos T; Cheng AC; Kedzierska K; Zhang X; Xu J; Kent SJ, 2017, 'Fc functional antibodies in humans with severe H7N9 and seasonal influenza', Journal of Clinical Investigation, 2, pp. e92750, http://dx.doi.org/10.1172/jci.insight.92750

Fennessey CM; Pinkevych M; Immonen TT; Reynaldi A; Venturi V; Nadella P; Reid C; Newman L; Lipkey L; Oswald K; Bosche WJ; Trivett MT; Ott DE; Estes JD; Del Prete GQ; Lifson JD; Davenport MP; Keele BF, 2017, 'Genetically-barcoded SIV facilitates enumeration of rebound variants and estimation of reactivation rates in nonhuman primates following interruption of suppressive antiretroviral therapy', Plos Pathogens, 13, pp. e1006359, http://dx.doi.org/10.1371/journal.ppat.1006359

Petravic J; Rasmussen TA; Lewin SR; Kent SJ; Davenport MP, 2017, 'Relationship between measures of HIV reactivation and decline of the latent reservoir under latencyreversing agents', Journal of Virology, 91, pp. 10.1128/jvi.02092 - 10.1128/jvi.02016, http://dx.doi.org/10.1128/JVI.02092-16

Lee WS; Kristensen AB; Tolstrup M; Østergaard L; Søgaard OS; Wines BD; Hogarth PM; Reynaldi A; Davenport M; Emery S; Amin J; Cooper DA; Kan V; Fox J; Grüll H; Parsons MS; Kent SJ; Rasmussen TA, 2017, '13 HIV-1-specific ADCC following anti-latency therapy and analytical treatment interruption', Journal of Virus Eradication, 3, pp. 10 - 10, http://dx.doi.org/10.1016/s2055-6640(20)30718-4

Griffin P; Pasay C; Elliott S; Sekuloski S; Sikulu M; Hugo L; Khoury D; Cromer D; Davenport M; Sattabongkot J; Ivinson K; Ockenhouse C; McCarthy J, 2016, 'Safety and Reproducibility of a Clinical Trial System Using Induced Blood Stage Plasmodium vivax Infection and Its Potential as a Model to Evaluate Malaria Transmission', Plos Neglected Tropical Diseases, 10, pp. e0005139, http://dx.doi.org/10.1371/journal.pntd.0005139

Alinejad-Rokny H; Anwar F; Waters SA; Davenport MP; Ebrahimi D, 2016, 'Source of CpG depletion in the HIV-1 genome', Molecular Biology and Evolution, 33, pp. 3205 - 3212, http://dx.doi.org/10.1093/molbev/msw205

Reynaldi A; Schlub TE; Piriou E; Ogolla S; Sumba OP; Moormann AM; Rochford R; Davenport MP, 2016, 'Modeling of EBV Infection and Antibody Responses in Kenyan Infants with Different Levels of Malaria Exposure Shows Maternal Antibody Decay is a Major Determinant of Early EBV Infection', Journal of Infectious Diseases, 214, pp. 1390 - 1398, http://dx.doi.org/10.1093/infdis/jiw396

Reynaldi A; Smith NL; Schlub TE; Venturi V; Rudd BD; Davenport MP, 2016, 'Modeling the dynamics of neonatal CD8+ T-cell responses', Immunology and Cell Biology, 94, pp. 838 - 848, http://dx.doi.org/10.1038/icb.2016.47

Khoury DS; Cromer D; Möhrle JJ; McCarthy JS; Davenport MP, 2016, 'Defining the effectiveness of antimalarial chemotherapy: Investigation of the lag in parasite clearance following drug administration', Journal of Infectious Diseases, 214, pp. 753 - 761, http://dx.doi.org/10.1093/infdis/jiw234

Pinkevych M; Cromer D; Tolstrup M; Grimm AJ; Cooper DA; Lewin SR; Søgaard OS; Rasmussen TA; Kent SJ; Kelleher AD; Davenport MP, 2016, 'Erratum: HIV Reactivation from Latency after Treatment Interruption Occurs on Average Every 5-8 Days-Implications for HIV Remission (PLoS Pathogens (2015) 11:7 (e1005000) DOI: 10.1371/journal.ppat.1005000)', PLoS Pathogens, 12, pp. e1005745, http://dx.doi.org/10.1371/journal.ppat.1005745

Pinkevych M; Kent SJ; Tolstrup M; Lewin SR; Cooper DA; Søgaard OS; Rasmussen TA; Kelleher AD; Cromer D; Davenport MP, 2016, 'Modeling of Experimental Data Supports HIV Reactivation from Latency after Treatment Interruption on Average Once Every 5–8 Days', Plos Pathogens, 12, pp. e1005740, http://dx.doi.org/10.1371/journal.ppat.1005740

Adekunle AI; Cromer D; Davenport MP, 2016, 'Artemisinin-based treatments in pregnant women with malaria', New England Journal of Medicine, 375, pp. 283, http://dx.doi.org/10.1056/NEJMc1604709

D'Alessandro U; PREGACT Study Group , 2016, 'Artemisinin-Based Treatments in Pregnant Women with Malaria.', N Engl J Med, 375, pp. 283 - 284, http://dx.doi.org/10.1056/NEJMc1604709

Younes SA; Freeman ML; Mudd JC; Shive CL; Reynaldi A; Panigrahi S; Estes JD; Deleage C; Lucero C; Anderson J; Schacker TW; Davenport MP; McCune JM; Hunt PW; Lee SA; Serrano-Villar S; Debernardo RL; Jacobson JM; Canaday DH; Sekaly RP; Rodriguez B; Sieg SF; Lederman MM, 2016, 'IL-15 promotes activation and expansion of CD8+ T cells in HIV-1 infection', Journal of Clinical Investigation, 126, pp. 2745 - 2756, http://dx.doi.org/10.1172/JCI85996

Ortiz AM; Carnathan DG; Yu J; Sheehan KM; Kim P; Reynaldi A; Vanderford TH; Klatt NR; Brenchley JM; Davenport MP; Silvestri G, 2016, 'Analysis of the in vivo turnover of CD4+ T-cell subsets in chronically SIV-infected sooty mangabeys', Plos One, 11, pp. e0156352, http://dx.doi.org/10.1371/journal.pone.0156352

Lloyd SB; Lichtfuss M; Amarasena TH; Alcantara S; De Rose R; Tachedjian G; Alinejad-Rokny H; Venturi V; Davenport MP; Winnall WR; Kent SJ, 2016, 'High fidelity simian immunodeficiency virus reverse transcriptase mutants have impaired replication in vitro and in vivo', Virology, 492, pp. 1 - 10, http://dx.doi.org/10.1016/j.virol.2016.02.008

Cromer D; Schlub TE; Smyth RP; Grimm AJ; Chopra A; Mallal S; Davenport MP; Mak J, 2016, 'HIV-1 mutation and recombination rates are different in macrophages and T-cells', Viruses, 8, pp. 118, http://dx.doi.org/10.3390/v8040118

Reynaldi A; Schlub TE; Chelimo K; Sumba PO; Piriou E; Ogolla S; Moormann AM; Rochford R; Davenport MP, 2016, 'Impact of Plasmodium falciparum Coinfection on Longitudinal Epstein-Barr Virus Kinetics in Kenyan Children', Journal of Infectious Diseases, 213, pp. 985 - 991, http://dx.doi.org/10.1093/infdis/jiv525

Venturi V; Nzingha K; Amos TG; Charles WC; Dekhtiarenko I; Cicin-Sain L; Davenport MP; Rudd BD, 2016, 'The neonatal CD8+ T cell repertoire rapidly diversifies during persistent viral infection', Journal of Immunology, 196, pp. 1604 - 1616, http://dx.doi.org/10.4049/jimmunol.1501867

Cromer D; Grimm AJ; Schlub TE; Mak J; Davenport MP, 2016, 'Estimating the in-vivo HIV template switching and recombination rate', AIDS, 30, pp. 185 - 192, http://dx.doi.org/10.1097/QAD.0000000000000936

Pinkevych M; Reynaldi A; Fennessey C; Reid C; Nadella P; Lipkey L; Newman L; Ayala V; Jain S; Del Prete G; Estes J; Ott D; Lifson J; Ohlen C; Keele B; Davenport M, 2016, 'OA2-1 Frequent and ‘burst-like’ reactivation from latency in SIVmac239M infected macaques', Journal of Virus Eradication, 2, pp. 2 - 2, http://dx.doi.org/10.1016/s2055-6640(20)31008-6

, 2016, 'Oral abstracts of the 21st International AIDS Conference 18-22 July 2016, Durban, South Africa.', J Int AIDS Soc, 19, pp. 21264, http://dx.doi.org/10.7448/IAS.19.6.21264

Haqqani AA; Marek SL; Kumar J; Davenport M; Wang H; Tilton JC, 2015, 'Central memory CD4+ T cells are preferential targets of double infection by HIV-1 Retroviruses', Virology Journal, 12, pp. 184, http://dx.doi.org/10.1186/s12985-015-0415-0

Pinkevych M; Cromer D; Tolstrup M; Grimm AJ; Cooper DA; Lewin SR; Søgaard OS; Rasmussen TA; Kent SJ; Kelleher AD; Davenport MP, 2015, 'HIV Reactivation from Latency after Treatment Interruption Occurs on Average Every 5-8 Days—Implications for HIV Remission', Plos Pathogens, 11, pp. e1005000, http://dx.doi.org/10.1371/journal.ppat.1005000

Khoury DS; Cromer D; Best SE; James KR; Sebina I; Haque A; Davenport MP, 2015, 'Reduced erythrocyte susceptibility and increased host clearance of young parasites slows Plasmodium growth in a murine model of severe malaria', Scientific Reports, 5, pp. 9412, http://dx.doi.org/10.1038/srep09412

Martyushev AP; Petravic J; Grimm AJ; Alinejad-Rokny H; Gooneratne SL; Reece JC; Cromer D; Kent SJ; Davenport MP, 2015, 'Epitope-specific CD8+ T cell kinetics rather than viral variability determine the timing of immune escape in simian immunodeficiency virus infection', Journal of Immunology, 194, pp. 4112 - 4121, http://dx.doi.org/10.4049/jimmunol.1400793

Waugh C; Cromer D; Grimm A; Chopra A; Mallal S; Davenport M; Mak J, 2015, 'A general method to eliminate laboratory induced recombinants during massive, parallel sequencing of cDNA library', Virology Journal, 12, pp. 55, http://dx.doi.org/10.1186/s12985-015-0280-x

Pinkevych M; Petravic J; Bereczky S; Rooth I; Färnert A; Davenport MP, 2015, 'Understanding the relationship between plasmodium falciparum growth rate and multiplicity of infection', Journal of Infectious Diseases, 211, pp. 1121 - 1127, http://dx.doi.org/10.1093/infdis/jiu561

Adekunle AI; Pinkevych M; McGready R; Luxemburger C; White LJ; Nosten F; Cromer D; Davenport MP, 2015, 'Modeling the Dynamics of Plasmodium vivax Infection and Hypnozoite Reactivation In Vivo', Plos Neglected Tropical Diseases, 9, pp. e0003595, http://dx.doi.org/10.1371/journal.pntd.0003595

Tey SK; Davenport MP; Hill GR; Kennedy GA; Durrant ST; Khanna R; Cromer D, 2015, 'Post transplant CMV-specific T-cell immune reconstitution in the absence of global T-cell immunity is associated with a high risk of subsequent virus reactivation', Bone Marrow Transplantation, 50, pp. 315 - 316, http://dx.doi.org/10.1038/bmt.2014.265

Pinkevych M; Chelimo K; Vulule J; Kazura JW; Moormann AM; Davenport MP, 2015, 'Time-to-infection by Plasmodium falciparum is largely determined by random factors', BMC Medicine, 13, pp. 19, http://dx.doi.org/10.1186/s12916-014-0252-9

Liehl P; Meireles P; Albuquerque IS; Pinkevych M; Baptista F; Mota MM; Davenport MP; Prudêncio M, 2015, 'Innate immunity induced by Plasmodium liver infection inhibits malaria reinfections', Infection and Immunity, 83, pp. 1172 - 1180, http://dx.doi.org/10.1128/IAI.02796-14

Back to profile page